For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 24-30, 2026
FDA and innovation FDA and CMS move on personalized gene therapies. The FDA released draft guidance that lets developers of…
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Blog
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated…
Search Posts
Blog
Big Beautiful Bill threatens the Costco of health care
You’ve probably never wondered why you buy peanut butter from the grocery store instead of directly from the J.M. Smucker Company or your TV…
News Release
MAHA Commission recommendations on improving government-directed research merit consideration
President Trump’s Make America Healthy Again Commission released the “Making Our Children Health Again” report, which seeks to evaluate health trends among America’s…
Blog
States can keep Medicaid whole if they want
Congress is considering slowing Medicaid growth over the next 10 years enough to reduce federal spending by $625 billion. Many Republicans argue that…
The Washington Examiner
Capping drug prices will cripple innovation and harm public health
The Washington Examiner cited CEI’s expert on life-saving drugs and technology The Competitive Enterprise Institute was similarly scathing. “As with many industries, the…
Blog
Free the Economy podcast: Reforming Medicaid with Brian Blase
In a recent episode we cover biofuels and farm tariffs, the decline in green investing, and the effort to stop state…
The Epoch Times
What to Know About Trump’s Plan to Slash Drug Prices
The Epoch Times cited CEI’s expert on drug prices “Jeremy Nighohossian, a senior fellow at the Competitive Enterprise Institute, a libertarian think tank,…